The German pharmaceutical company Boehringer Ingelheim said recently that only Uganda and Botswana have accepted its offer of free supplies of nevirapine, the drug used to prevent mother-to-child HIV transmission. The low take-up of Boehringer's offer highlights that, in addition to more funds and cheaper drugs, an effective response to the AIDS epidemic also requires strong political will from African countries. But some AIDS activists have criticized the way drug companies run donation programs...Boehringer has been criticized for the complicated bureaucracy of the drug program.